BWA-522

N/A

Report date: 2023/10/12 14:50:50
NMEFirst In Class

Base Information

Drug NameBWA-522
Drug Alias NameBWA-522
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen receptor splice variant 7 degradersAndrogen Receptor degraders
TargetsAndrogen receptor splice variant 7Androgen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesOcean University Of China
China Registration ClassN/A

Develop Information

Active CompaniesOcean University Of China
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A